Skip to main content
OpenTrials

Clinical trial condition

Metastatic Breast Cancer

Explore clinical trials studying Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

643 public trials 134 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Breast Cancer trial results

Recruiting

HER2 Targeted Molecular Imaging in mBC and Other Metastatic Solid Carcinomas Using 68Ga-ABS011

NCT06369831

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +9 more
Locations
  • Medizinische Universität Innsbruck Innsbruck, Tyrol, Austria
  • AZ Delta CHIREC Brussels, Brussels Capital, Belgium
  • Cliniques Universitaires Saint-Luc Brussels, Brussels Capital, Belgium
  • Free University Brussels (VUB) Brussels, Brussels Capital, Belgium
View Trial Details
Recruiting

A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors

NCT06533332

Conditions
Adnexal Diseases, Advanced Solid Tumor, Breast Diseases, +31 more
Locations
  • Macquarie University Health Ryde, New South Wales, Australia
  • The Kinghorn Cancer Center Sydney, New South Wales, Australia
  • Westmead Hospital Westmead, New South Wales, Australia
  • Cancer Research SA Adelaide, South Australia, Australia
View Trial Details
Recruiting

A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer

NCT06678269

Conditions
Breast Cancer, Breast Cancer Metastatic, Breast Cancer Stage IV, +11 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (All protocol activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities ) Commack, New York, United States
View Trial Details
Recruiting

Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns

NCT06551220

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • Dana-Farber Cancer Institute, Harvard Medical School Boston, Massachusetts, United States
  • Fujian Cancer Hospital, Fujian Medical University Fuzhou, Fujian, China
  • The 10th Affiliated Hospital of Southern Medical University Dongguan, Guangdong, China
View all 26 locations
View Trial Details
Recruiting

A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Anti-tumor Activity of Autologous p95HER2.CAR-TECH2Me T Cells in Patients With Selected Advanced Cancers.

NCT07593820

Conditions
Breast Diseases, Breast Neoplasms, Digestive System Diseases, +12 more
Locations
  • Hospital Del Mar Barcelona, Catalonia, Spain
  • Hospital Universitari Vall D Hebron Barcelona, Catalonia, Spain
View Trial Details
Recruiting

A Study of Surgery and Radiotherapy in People With Breast Cancer

NCT07053085

Conditions
Breast Diseases, Breast Neoplasms, HER2-positive Breast Cancer, +5 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ) Commack, New York, United States
View Trial Details

Related conditions